IP Library Granted Patent US 11,208,682
Granted Patent B2
US 11,208,682 · App. 16/569,823 · Granted Dec 28, 2021

Enhanced optical detection for nucleic acid sequencing using thermally-dependent fluorophore tags

Inventors: Patrick Braganca (San Jose, CA); Daniel Bedau (San Jose, CA)
Assignee: Western Digital Technologies, Inc.
C12Q1/6816B01L3/502B01L7/52B01L2200/147B01L2300/0663B01L2300/1805
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,208,682
App. No.
16/569,823
Granted
Dec 28, 2021
Kind
B2
Abstract

Disclosed herein are improved methods and systems for sequencing nucleic acid that exploit the temperature-dependence of the emitted intensity of fluorescent dyes. The temperature of the sequencing reaction is adjusted during each sequencing cycle, and the emission, or lack of emission, of light meeting or exceeding a threshold by the fluorescent dyes at different temperatures, or within different temperature ranges, is used to detect the fluorescent labels of the incorporated dNTPs and thereby sequence the nucleic acid. The disclosed methods enable a determination of the dNTP incorporated at any given site with a reasonable number of chemistry steps without the complex optics necessary for prior-art systems.

Claims (49)

1. A method of sequencing nucleic acid using a sequencing apparatus comprising a fluidic channel having a plurality of sites for attaching, to a surface of the fluidic channel, a plurality of nucleic acid strands to be sequenced, the method comprising:

in one or more rounds of addition, adding, to the fluidic channel, (i) the plurality of nucleic acid strands, (ii) a plurality of molecules of nucleic acid polymerase, (iii) a first fluorescently-labeled nucleotide precursor comprising a first fluorescent label, wherein, when excited into fluorescence, an intensity of light emitted by the first fluorescent label is greater than or equal to a first threshold in a first temperature range and in a second temperature range, the second temperature range being lower than the first temperature range, and (iv) a second fluorescently-labeled nucleotide precursor comprising a second fluorescent label, wherein, when excited into fluorescence, an intensity of light emitted by the second fluorescent label is less than or equal to a second threshold in the first temperature range and greater than or equal to the second threshold in the second temperature range, wherein the first and second fluorescent labels are chemically distinct from each other;

using a heater, setting a temperature within the fluidic channel to be within the first temperature range;

using an imaging system, detecting a first intensity at each of the plurality of sites while the temperature of the fluidic channel is within the first temperature range;

in response to the first intensity at a particular site of the plurality of sites being greater than or equal to a first value, determining that the first fluorescently-labeled nucleotide precursor has been incorporated into an extendable primer at the particular site;

using the heater, setting the temperature within the fluidic channel to be within the second temperature range;

using the imaging system, detecting a second intensity at each of the plurality of sites while the temperature of the fluidic channel is within the second temperature range; and

in response to the second intensity at the particular site being greater than or equal to a second value and the first intensity at the particular site being less than the first value, determining that the second fluorescently-labeled nucleotide precursor has been incorporated into the extendable primer at the particular site.

2. The method of claim 1 , wherein the first and second thresholds are approximately the same.

3. The method of claim 1 , wherein the first and second thresholds are different.

4. The method of claim 1 , wherein the first and second values are approximately the same.

5. The method of claim 1 , wherein the first and second values are different.

6. The method of claim 1 , wherein:

the first value is the first threshold, and

the second value is the second threshold.

7. The method of claim 1 , wherein:

the first value is based on the first threshold, and

the second value is based on the second threshold.

8. The method of claim 1 , further comprising:

adding, to the fluidic channel, a third fluorescently-labeled nucleotide precursor comprising a third fluorescent label, wherein, when excited into fluorescence, an intensity of light emitted by the third fluorescent label is less than a third threshold in the first and second temperature ranges and greater than or equal to the third threshold in a third temperature range, the third temperature range being lower than the second temperature range, wherein the third fluorescent label is chemically distinct from each of the first and second fluorescent labels;

using the heater, setting the temperature within the fluidic channel to be within the third temperature range;

using the imaging system, detecting a third intensity at each of the plurality of sites while the temperature of the fluidic channel is within the third temperature range; and

in response to the third intensity at the particular site being greater than or equal to a third value, and the first intensity at the particular site being less than the first value, and the second intensity at the particular site being less than the second value, determining that the third fluorescently-labeled nucleotide precursor has been incorporated into the extendable primer at the particular site.

9. The method of claim 8 , wherein the first, second, and third fluorescently-labeled nucleotide precursors are added to the fluidic channel at substantially the same time.

10. The method of claim 8 , further comprising:

in response to the first intensity at the particular site being less than the first value, and the second intensity at the particular site being less than the second value, and the third intensity at the particular site being less than the third value, determining that a fourth, unlabeled precursor has been incorporated into the extendable primer at the particular site.

11. The method of claim 10 , wherein at least two of the first, second, and third thresholds are approximately the same.

12. The method of claim 10 , wherein the first and second thresholds are different.

13. The method of claim 10 , wherein at least two of the first, second, and third values are approximately the same.

14. The method of claim 10 , wherein the first, second, and third values are different.

15. The method of claim 8 , further comprising:

adding, to the fluidic channel, a fourth fluorescently-labeled nucleotide precursor comprising a fourth fluorescent label, wherein, when excited into fluorescence, an intensity of light emitted by the fourth fluorescent label is less than a fourth threshold in each of the first, second, and third temperature ranges and greater than or equal to the fourth threshold in a fourth temperature range, the fourth temperature range being lower than the third temperature range, wherein the fourth fluorescent label is chemically distinct from each of the first, second, and third fluorescent labels;

using the heater, setting the temperature within the fluidic channel to be within the fourth temperature range;

using the imaging system, detecting a fourth intensity at each of the plurality of sites while the temperature of the fluidic channel is within the fourth temperature range; and

in response to the fourth intensity at the particular site being greater than or equal to a fourth value, and the first intensity at the particular site being less than the first value, and the second intensity at the particular site being less than the second value, and the third intensity at the particular site being less than the third value, determining that the fourth fluorescently-labeled nucleotide precursor has been incorporated into the extendable primer at the particular site.

16. The method of claim 15 , wherein two or more of the first, second, third, and fourth thresholds are approximately the same.

17. The method of claim 15 , wherein two or more of the first, second, third, and fourth values are approximately the same.

18. The method of claim 15 , wherein the first, second, third, and fourth fluorescently-labeled nucleotide precursors are added to the fluidic channel at substantially the same time.

19. A system for carrying out the method of claim 1 , the system comprising:

the fluidic channel;

the heater;

the imaging system, wherein the imaging system is configured to detect an intensity of light emitted at each of the plurality of sites in each of the first and second temperature ranges; and

at least one processor coupled to the imaging system and configured to execute at least one machine-readable instruction that, when executed, causes the at least one processor to:

instruct the heater to set the temperature within the fluidic channel to be within the first temperature range;

obtain, from the imaging system, an indication of the first intensity at each of the plurality of sites while the temperature of the fluidic channel is within the first temperature range;

instruct the heater to set the temperature within the fluidic channel to be within the second temperature range;

obtain, from the imaging system, an indication of the second intensity at each of the plurality of sites while the temperature of the fluidic channel is within the second temperature range;

in response to the first intensity at the particular site of the plurality of sites being greater than or equal to the first value, determine that the first fluorescently-labeled nucleotide precursor has been incorporated into the extendable primer at the particular site; and

in response to the second intensity at the particular site being greater than or equal to the second value and the first intensity at the particular site being less than the first value, determine that the second fluorescently-labeled nucleotide precursor has been incorporated into the extendable primer at the particular site.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2025
From: SANDISK TECHNOLOGIES, INC.
To: WESTERN DIGITAL TECHNOLOGIES, INC.
Reel/Frame 070313/0706 →
SECURITY AGREEMENT (SUPPLEMENTAL) Recorded Nov 14, 2024
From: SANDISK TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 069411/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2024
From: WESTERN DIGITAL TECHNOLOGIES, INC.
To: SANDISK TECHNOLOGIES, INC.
Reel/Frame 069169/0572 →
PATENT COLLATERAL AGREEMENT - A&R LOAN AGREEMENT Recorded Aug 21, 2023
From: WESTERN DIGITAL TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 064715/0001 →
PATENT COLLATERAL AGREEMENT - DDTL LOAN AGREEMENT Recorded Aug 21, 2023
From: WESTERN DIGITAL TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 067045/0156 →
RELEASE OF SECURITY INTEREST AT REEL 052915 FRAME 0566 Recorded Feb 8, 2022
From: JPMORGAN CHASE BANK, N.A.
To: WESTERN DIGITAL TECHNOLOGIES, INC.
Reel/Frame 059127/0001 →
SECURITY INTEREST Recorded Feb 6, 2020
From: WESTERN DIGITAL TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS AGENT
Reel/Frame 052915/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: BRAGANCA, PATRICK; BEDAU, DANIEL
To: WESTERN DIGITAL TECHNOLOGIES, INC.
Reel/Frame 050365/0795 →
Continuity (1)
Related Publication 20210079455A1 · Mar 18, 2021